Can Breakthrough Infections Lead to Long COVID? For an Unlucky Few, Yes

When health experts talk about the remarkable efficacy of COVID-19 vaccines, they typically point to their ability to prevent severe disease and death. Fully vaccinated people can still get “breakthrough” infections from the virus that causes COVID-19—but compared to an unvaccinated person, they’re more than 10 times less likely to be hospitalized or die from their illness, according to U.S. Centers for Disease Control and Prevention (CDC) research. Officials often point to these impressive figures as evidence that we can tame COVID-19 into a mostly mild illness that behaves like a routine cold or flu, and thus with which we can coexist. After all, the vaccines were not designed to quash viral spread entirely; they were designed to defang the virus by preventing its worst outcomes. [time-brightcove not-tgx=”true”] But people like April Zaleski know COVID-19’s worst outcomes aren’t limited to severe disease and death, even for the fully vaccinated. Zaleski, a 32-year-old from Idaho, caught COVID-19 in July 2021 after being vaccinated in January. She recovered after a couple weeks and thought the worst was behind her. But then her fatigue came back with force, along with brain fog, shortness of breath, vertigo and a skyrocketing heart rate. She began to suspect she had Long COVID, the name adopted by people who suffer symptoms long after their initial infection. Long COVID “was on my radar,” Zaleski says, “but ha...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Related Links:

This article describes structural, procedural, and functional changes developed in a pediatric ED to respond to the COVID-19 pandemic. The discussion also includes case studies to illustrate the changes made.
Source: Nursing - Category: Nursing Tags: Feature Source Type: research
An advisory panel to the F.D.A. will consider Pfizer ’s application for those ages 5-to-11 on Tuesday.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Children and Childhood Johnson & Moderna Inc Pfizer Inc Fauci, Anthony S United States Source Type: news
No abstract available
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Online Letters to the Editor Source Type: research
No abstract available
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Online Letters to the Editor Source Type: research
Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership rapidly designed a unique therapeutic agent intake and assessment process for candidate treatments of coronavirus disease 2019. These treatments included antivirals, immune modulators, severe acute respiratory syndrome coronavirus 2 neutralizing antibodies, and organ-supportive treatments at both the preclinical and clinical stages of development. The ACTIV Therapeutics-Clinical Working Group Agent Prioritization subgroup e...
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Review Article Source Type: research
No abstract available
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Editorials Source Type: research
CONCLUSIONS: Endothelial dysfunction is associated with severe acute respiratory syndrome coronavirus 2–related multisystem inflammatory syndrome in children with shock and may constitute one of the underlying mechanisms.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Online Brief Reports Source Type: research
CONCLUSIONS: The majority of coronavirus disease 2019 survivors following ICU in our cohort had returned to work by 6 months of follow-up. However, most of them reported reduced work effectiveness. Prolonged sick leave and unemployment were common findings in those not returning.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Online Brief Reports Source Type: research
No abstract available
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Online Letters to the Editor Source Type: research
CONCLUSIONS: There was a marked deterioration in outcomes for patients admitted to critical care at the peak of the second wave of coronavirus disease 2019 in United Kingdom (December 2020–January 2021), compared with the post-first-wave period (June 2020–September 2020). The deterioration was independent of recorded patient characteristics and occupancy levels. Further research is required to determine to what extent this deterioration reflects the impact of the B117 variant of concern.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Feature Articles Source Type: research
More News: Autoimmune Disease | Brain | Cardiology | Centers for Disease Control and Prevention (CDC) | Chronic Fatigue Syndrome | COVID-19 | Disability | Funding | Health | Health Management | Heart | Hospitals | Infectious Diseases | International Medicine & Public Health | Israel Health | Lyme Disease | National Institutes of Health (NIH) | Neurology | Pandemics | Politics | Study | Vaccines | Vertigo | Women | Yale